Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Injured Myocardium
- Molecular classification
- Tissue, Cardiac Muscle
01
Overview
The term "injured myocardium" refers to heart muscle (myocardial) tissue that has sustained damage. This injury is most commonly identified by an elevation in cardiac troponin levels. It disrupts normal cardiac function, potentially leading to arrhythmias, impaired contractility, or even heart failure depending on severity and extent. Causes can be ischemic, non-ischemic, or systemic.
- Other names
- Myocardial InjuryDamaged Heart Muscle
02
Biological functions
Heart ContractionPumping BloodCardiac Function
03
Disease associations
Myocardial InfarctionCardiomyopathyHeart FailureArrhythmiaIschemia
04
Safety considerations
ArrhythmiasHeart FailureImpaired Cardiac Contractility
05
Biomarkers
Cardiac TroponinsCK-MB
Beyond the preview
Go deeper on Injured Myocardium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Injured Myocardium.